skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Cellulose binding domain proteins

Abstract

A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.

Inventors:
; ; ;
Publication Date:
Research Org.:
University of California
Sponsoring Org.:
USDOE, Washington, DC (United States)
OSTI Identifier:
675819
Patent Number(s):
US 5,837,814/A/
Application Number:
PAN: 8-460,455
Assignee:
Yissum Research Development Co., Jerusalem (Israel); Univ. of California, Davis, CA (United States) PTO; SCA: 550200; 550600; PA: EDB-99:003692; SN: 98002027945
DOE Contract Number:
FG03-92ER20069
Resource Type:
Patent
Resource Relation:
Other Information: PBD: 17 Nov 1998
Country of Publication:
United States
Language:
English
Subject:
55 BIOLOGY AND MEDICINE, BASIC STUDIES; CELLULOSE; AFFINITY; PROTEINS; DRUGS; DIAGNOSTIC TECHNIQUES; CHEMICAL BONDS

Citation Formats

Shoseyov, O., Shpiegl, I., Goldstein, M., and Doi, R.. Cellulose binding domain proteins. United States: N. p., 1998. Web.
Shoseyov, O., Shpiegl, I., Goldstein, M., & Doi, R.. Cellulose binding domain proteins. United States.
Shoseyov, O., Shpiegl, I., Goldstein, M., and Doi, R.. 1998. "Cellulose binding domain proteins". United States. doi:.
@article{osti_675819,
title = {Cellulose binding domain proteins},
author = {Shoseyov, O. and Shpiegl, I. and Goldstein, M. and Doi, R.},
abstractNote = {A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = 1998,
month =
}
  • A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.
  • A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.
  • A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques. 16 figs.
  • A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production thereof. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques.
  • A cellulose binding domain (CBD) having a high affinity for crystalline cellulose and chitin is disclosed, along with methods for the molecular cloning and recombinant production thereof. Fusion products comprising the CBD and a second protein are likewise described. A wide range of applications are contemplated for both the CBD and the fusion products, including drug delivery, affinity separations, and diagnostic techniques.